-
The Future of Breast Cancer Screening?
At Waters, we’re constantly innovating our mass spectrometry systems to improve human health, like this groundbreaking advance in breast cancer detection.
Recent Posts
Waters Employee Jenn Glabicky is Delivering Benefit in the Fight Against COVID-19
April 20th was just another Monday for most. In Massachusetts, it was Patriots’ Day which is a local holiday commemorating the early battles of the American Revolutionary War and when many schools and banks are closed in observance. But, for thousands around the world, it was the day they were supposed to run in the world-famous Boston Marathon....
In the Fight against COVID-19, Science is Surging!
This blog was originally posted on LinkedIn From the very beginning of the COVID-19 pandemic, we knew our customers would need an unprecedented amount of scientific and technical support. That is why we quickly created a “COVID-19 Innovation Response Team” to bring Waters’ industry-leading expertise to the forefront of the global scientific surge to quickly and effectively...
Setting a New Bar for Benchtop Automation
Laboratory automation is quickly becoming a critical component of the modern lab, streamlining pharmaceutical, life science and analytical LC-MS workflows. Automation of routine and complex sample preparation helps minimize variability, improve traceability and simplify method transfer, ultimately bringing improved efficiency to the lab and allowing scientists to spend more time on value-added tasks. Despite this,...
Waters Introduces STEM Live: The Science of What’s Possible for Kids
In an earlier blog, we discussed how the skills that students develop in science, technology, engineering and math—disciplines collectively known as STEM, are more important than ever. At Waters, we are actively engaging in global, on-site STEM-focused training programs for young students through collaborations with NGOs like Junior Achievement. These programs often include classroom-based learning,...
Navigating the Uncertainties of the Nitrosamine Impurity Crisis
The nitrosamine impurity crisis continues to be on the mind of every stakeholder involved in the development and manufacturing of affected drug products. In our interactions with key opinion leaders and those in the lab having to develop and validate nitrosamine testing methods, we’ve come across a few common questions that we want to address here
Data Integrity Matters: Unknown, Unintegrated or Undetected Chromatography Peaks
In an earlier blog, I discussed the concerns about extraneous peaks that might appear in LC separations. While there can be many sources for peaks unrelated to the test substances, how do you decide which are legitimate, and which are an indication of poor quality? Which are harmless and which are dangerous? Which are expected...
Popular Topics
ACQUITY QDa (16) bioanalysis (11) biologics (14) biopharma (26) biopharmaceutical (36) biosimilars (11) biotherapeutics (16) case study (16) chromatography (14) data integrity (21) food analysis (12) HPLC (15) LC-MS (21) liquid chromatography (LC) (19) mass detection (15) mass spectrometry (MS) (54) method development (13) STEM (12)